Kanglexin is a novel oral anthraquinone that inhibits NLRP3 inflammasome-driven pyroptosis, providing cardioprotection. It promotes angiogenesis via FGFR1/ERK signaling for diabetic wound healing and exhibits anti-atherosclerotic potential by lowering lipids and inhibiting vascular smooth muscle cell dedifferentiation in research models.
Molecular Weight:
398.36
CAS Number:
[2228847-12-7]
Formula:
C21H18O8
Target:
Pyroptosis,FGFR,AMPK,ERK,NOD-like Receptor (NLR)
* VAT and and shipping costs not included. Errors and price changes excepted